Welcome to the Parkins Laboratory!

Our group performs translational research in cystic fibrosis lung disease and Wastewater-based surveillance (WBS).

 

RECENT LAB NEWS:

  • Congratulation to Nicole and collaborators who have recently published a manuscript entitled “Surveillance for SARS-CoV-2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreak” (2023).
  • Congratulation to Nicole and collaborators who have recently published a manuscript entitled “Longitudinal SARS-CoV-2 RNA wastewater monitoring across a range of scales correlates with total and regional COVID-19 burden in a well-defined urban population” (2022).
  • Congratulation to Nicole and collaborators who have recently published a manuscript entitled “A multicenter study investigating SARS-CoV-2 in tertiary-care hospital wastewater. viral burden correlates with increasing hospitalized cases as well as hospital-associated transmissions and outbreaks” (2021).
  • Congratulation to Nicole and collaborators who have recently published a manuscript entitled “Azithromycin and the microbiota of cystic fibrosis sputum” (2021).
  • Congratulation to Conrad and collaborators who have recently published a manuscript entitled "Epidemiology of E. coli in Cystic Fibrosis Airways Demonstrates the Capacity for Persistent Infection but Not Patient-Patient Transmission" (2020). 
  • Congratulation to Alya  and collaborators who have recently published a manuscript entitled “Sputum microbiota in adults with CF associates with response to inhaled tobramycin” (2020).

  • Congratulation to our team members for the Cystic Fibrosis Foundation (CFF) grant (2020) obtained, entitled " A longitudinal study of infection transmission in cystic fibrosis".

  • Congratulation to our team members for the CIHR grant (2020-2021) obtained, entitled " Wastewater surveillance of SARS-COV2 to enable real-time clinical case-finding in Calgary".

  • Congratulation to Nicole and collaborators who have recently published a manuscript entitled “Cystic fibrosis patients infected with epidemic Pseudomonas aeruginosa strains have unique microbial communities” (2020). Click here to access the manuscript. 

  • Congratulation to Conrad and collaborators who have recently published a manuscript entitled “Epidemiology of E. coli in cystic fibrosis airways demonstrates the capacity for persistent infection but not patient-patient transmission” (2020). Click here to access the manuscript. 

  • Congratulation to Fiona and collaborators who have recently published a manuscript entitled “Culture-enriched metagenomic sequencing enables in-depth profiling of the cystic fibrosis lung microbiota” (2020). Click here to access the manuscript. 

  • Congratulation to Alya Heirali, a PhD student within the Parkins laboratory who successfully defended her thesis entitled, “Exploring the mechanisms of inhaled antibiotics on the cystic fibrosis lung microbiome and Pseudomonas aeruginosa population diversity and their clinical implications” on December 10 2019.

  • Congratulation to our team members for the CIHR grant (2019-2024) obtained, entitled " The influence of Cytomegalovirus infection on cystic fibrosis disease progression".

  • Congratulation to Alya and collaborators who have recently published a manuscript entitled “The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome” (2019). Click here to access the manuscript. 

  • Congratulation to Taylor and collaborators who have recently published a manuscript entitled “A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome” (2019). Click here to access the manuscript. 

  • Congratulation to Taylor Woo, a Master student within the Parkins and Storey laboratories who successfully defended his thesis entitled, “Investigation into the natural history of Pseudomonas aeruginosa and the lung microbiome of non-cystic fibrosis bronchiectasis patients” on April 2017.

  • Congratulation to our team members for the CIHR grant (2016-2020) obtained, entitled "Reverse engineering cystic fibrosis lung disease: use of a comprehensive biorepository in the exploration of disease pathogenesis and outcomes".